<DOC>
	<DOCNO>NCT00177723</DOCNO>
	<brief_summary>The study evaluate improve performance pharmaco-statistical model previously develop compassionate use program patient treat linezolid clinical usage condition . This study also develop sensitive specific tool may use predict patient risk hematological toxicity , base factor include linezolid concentration duration therapy use model well understand determinant toxicity linezolid define better strategy manage toxicity reduce occurrence .</brief_summary>
	<brief_title>Towards Reducing Resistance Hematological Toxicity Linezolid</brief_title>
	<detailed_description>Epidemiologic information collect At baseline ( upon sign informed consent ) , follow information collect : Demographic data - age , sex , height , weight , state birth , previous pathology report associate bacteria subject contract , laboratory result , current medication use , prior medical problems/history . The following outcome measure assess : ( ) time resolution fever , ( b ) time normalization white blood cell count , ( c ) time microbiologic eradication infection , ( ) mortality 28 day follow onset infection . Blood work collect Hematological parameter : Patients include study require blood sample take determine platelet count hemoglobin baseline ( prior first dose linezolid ) , weekly whilst receive linezolid end linezolid treatment . Monitoring hematological parameter recommend part standard care patient treat linezolid great 2 week . This information collect participant 's medical record become part research record . Pharmacokinetic sample : On dos 4 5 Linezolid administration blood sample obtain patient 's vein prior first dose day intravenous ( IV ) oral Linezolid . Subsequent sample blood obtain eight hour period follow dose administration ( 2 hour , 4 hour 8 hour dose administration ) . About 5 ml one teaspoon obtain bedside nurse blood sample total 20 ml 4 teaspoonful . The GCRC staff travel patient 's hospital unit obtain blood sample necessary . If patient outpatient , patient ask come GCRC blood sample withdraw . If sample obtain prior first dose medicine day 2 3 dose administration , blood obtain patient 's vein around two separate dos day 2 3 day 3 4 . Blood obtain patient 's vein prior take next dose IV oral Linezolid two hour medicine administer . About 10 ml two teaspoonful obtain bedside nurse blood sample total 20 ml 4 teaspoonful . If patient develops decrease hematologic parameter ( define Hb &lt; 10 g/dL , WBC &lt; 2.5 , ANC &lt; 1.5 platelet &lt; 100 ) , blood collect patient 's vein immediately linezolid dose two hour medicine administer . At level , clinician care patient advise frequency hematologic monitoring increase three time weekly . If follow hematologic parameter occur , clinician advise investigator consider utilize alternative antibiotic : Hb &lt; 8 mg/dL , WBC &lt; 1.5 , ANC &lt; 1.0 , platelet &lt; 50 . It acknowledge investigator responsible care patient many factor may influence clinician 's decision continue switch linezolid therapy . The management decision make patient 's clinical team NOT investigator . The blood sample process store - 80Â° C freezer secure laboratory supervision principal investigator . These sample use determine amount Linezolid reach participant 's blood follow dose administration . All sample analyze obtain amount Linezolid find blood . No genetic testing perform sample obtain . The biologic sample ( blood ) control principal investigator research project . To protect confidentiality , personal identifier ( i.e. , name , social security number , birth date ) remove ( de-identified ) replace specific code number . The information link code number correspond subject ' identity keep separate , secure location . The investigator study keep sample indefinitely . Part biologic sample send Dr. Craig Rayner Monash University Australia . All sample send outside UPMC facility de-identified . Samples send Monash University keep Dr. Rayner 's laboratory . If subject withdraws provide request writing , sample collect already process destroy . All sample UPMC keep investigator 's laboratory locate Scaife Hall , Room 812 , 3550 Terrace Street . All patient see UPMC facility inpatient . If subject remove Linezolid clinically , subject require prolong use Linezolid subject 's hospitalization prolong clinically indicate .</detailed_description>
	<mesh_term>Linezolid</mesh_term>
	<criteria>Males female great 18 year age . All patient remain hospital pharmacokinetic sampling . All subject must medication linezolid part standard care . Patients renal failure receive peritoneal dialysis , hemodialysis hemofiltration . Any contraindication blood sampling</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>receive antibiotic Linezolid clinically</keyword>
</DOC>